Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
ACS Infectious Diseases|July 22, 2024
Challenges and Opportunities with Antibiotic Discovery and Exploratory ResearchLaura J V Piddock, Rohit Malpani, Alan HennessyChemical Communications (Cambridge, England)|May 12, 2015
Iron-mediated C-H coupling of arenes and unactivated terminal alkenes directed by sulfurCraig W Cavanagh, Miles H Aukland, Alan Hennessy, et al.Organic & Biomolecular Chemistry|May 21, 2016
Iron-mediated oxidative C-H coupling of arenes and alkenes directed by sulfur: an expedient route to dihydrobenzofuransCraig W Cavanagh, Miles H Aukland, Quentin Laurent, et al.Nature Reviews. Microbiology|March 28, 2025
Global health perspectives on antibacterial drug discovery and the preclinical pipelineUrsula Theuretzbacher, Ravindra P Jumde, Alan Hennessy, et al.The Lancet. Microbe|January 12, 2026
An overview of global public and philanthropic investments into antibacterial therapeutics (2017-23)Lloyd Czaplewski, Usha Lamichhane, Ralf Sudbrak, et al.ACS Infectious Diseases|February 23, 2026
AntibioticDB: An Updated and Improved Open-Access Database for the Antibacterial Research and Development CommunityLuiza H Galarion, Alan Hennessy, Simon D Harding, et al.Journal of Agricultural and Food Chemistry|September 23, 2024
Metproxybicyclone, a Novel Carbocyclic Aryl-dione Acetyl-CoA Carboxylase-Inhibiting Herbicide for the Management of Sensitive and Resistant Grass WeedsJames Nicholas Scutt, Nigel James Willetts, Breno Fernandes Campos, et al.Bioorganic & Medicinal Chemistry Letters|October 28, 2011
Novel cyclohexyl-amides as potent antibacterials targeting bacterial type IIA topoisomerasesTimothy J Miles, Christopher Barfoot, Gerald Brooks, et al.Bioorganic & Medicinal Chemistry Letters|November 4, 2011
Novel amino-piperidines as potent antibacterials targeting bacterial type IIA topoisomerasesTimothy J Miles, Jeffrey M Axten, Christopher Barfoot, et al.Nature|August 6, 2010
Type IIA topoisomerase inhibition by a new class of antibacterial agentsBenjamin D Bax, Pan F Chan, Drake S Eggleston, et al.Pageof 1